Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
For research & educational use only
Conducted between June 2011 and March 2013 at 191 sites in 27 countries in Europe, North America, South America, Asia, and Australia this was a randomised, placebo-controlled trial designed to evaluate the efficacy and safety of 3mg liraglutide 'injected subcutaneously once daily, as an adjunct to a reduced-calorie diet and increased physical activity, for weight management in overweight or obese adults who did not have diabetes at baseline.' A total of 3,731 individuals participated in the trial, of whom 2,487 were assigned to lifestyle intervention plus liraglutide and 1,244 to lifestyle intervention with a placebo
Body composition: Visual changes and how clothes fit
What sets Soraca Med apart is its commitment to patient-centered care
May help reduce psoriasis (6) Reduces cell damage in alcoholic and nonalcoholic fatty liver disease (7) Reduces insulin resistance in aging people (8) May reduce symptoms of Parkinsons Disease (9) May help fight autoimmune disease (10) May reduce respiratory disease symptoms (11) Eliminates poisons such as drugs and pollutants from our bodies
US$ 28.05
US$ 24.51
US$ 22.94
